SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-037147
Filing Date
2019-06-14
Accepted
2019-06-14 16:33:43
Documents
1
Period of Report
2019-06-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6395
  Complete submission text file 0001209191-19-037147.txt   7914
Mailing Address P. O. BOX # 110341 RESEARCH TRIANGLE PARK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4501 RESEARCH COMMONS, SUITE 100 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Issuer) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O TESARO, INC. 1000 WINTER STREET, SUITE 3300 WALTHAM MA 02451
Business Address
Nicholson Garry A (Reporting) CIK: 0001640861 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38096 | Film No.: 19899349